Literature DB >> 2359136

New colorimetric cytotoxicity assay for anticancer-drug screening.

P Skehan1, R Storeng, D Scudiero, A Monks, J McMahon, D Vistica, J T Warren, H Bokesch, S Kenney, M R Boyd.   

Abstract

We have developed a rapid, sensitive, and inexpensive method for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates. The method is suitable for ordinary laboratory purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per year. Cultures fixed with trichloroacetic acid were stained for 30 minutes with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid. Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extracted with 10 mM unbuffered Tris base [tris (hydroxymethyl)aminomethane] for determination of optical density in a computer-interfaced, 96-well microtiter plate reader. The SRB assay results were linear with the number of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence. The signal-to-noise ratio at 564 nm was approximately 1.5 with 1,000 cells per well. The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes. The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye. It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-volume, automated drug screening. SRB fluoresces strongly with laser excitation at 488 nm and can be measured quantitatively at the single-cell level by static fluorescence cytometry.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2359136     DOI: 10.1093/jnci/82.13.1107

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  1460 in total

1.  Implications for clinical pharmacodynamic studies of the statistical characterization of an in vitro antiproliferation assay.

Authors:  L M Levasseur; H Faessel; H K Slocum; W R Greco
Journal:  J Pharmacokinet Biopharm       Date:  1998-12

2.  Quantitative assessment of marine sponge cells in vitro: development of improved growth medium.

Authors:  R Willoughby; S A Pomponi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

3.  UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines.

Authors:  A Monks; E D Harris; A Vaigro-Wolff; C D Hose; J W Connelly; E A Sausville
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

4.  Heat shock and ceramide have different apoptotic pathways in radiation induced fibrosarcoma (RIF) cells.

Authors:  Hee-Jung Kim; Kong-Joo Lee
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

5.  Activity and DNA binding of new organoamidoplatinum (II) complexes.

Authors:  T Talarico; D R Phillips; G B Deacon; S Rainone; L K Webster
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

6.  Gompertzian growth pattern correlated with phenotypic organization of colon carcinoma, malignant glioma and non-small cell lung carcinoma cell lines.

Authors:  M A A Castro; F Klamt; V A Grieneisen; I Grivicich; J C F Moreira
Journal:  Cell Prolif       Date:  2003-04       Impact factor: 6.831

7.  Antioxidant activity of topiramate: an antiepileptic agent.

Authors:  N Cárdenas-Rodríguez; E Coballase-Urrutia; B Huerta-Gertrudis; M E García-Cruz; J Pedraza-Chaverri; R Coria-Jiménez; C Bandala; M Ruíz-García
Journal:  Neurol Sci       Date:  2012-06-04       Impact factor: 3.307

8.  Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target.

Authors:  Yongyuth Yuthavong; Bongkoch Tarnchompoo; Tirayut Vilaivan; Penchit Chitnumsub; Sumalee Kamchonwongpaisan; Susan A Charman; Danielle N McLennan; Karen L White; Livia Vivas; Emily Bongard; Chawanee Thongphanchang; Supannee Taweechai; Jarunee Vanichtanankul; Roonglawan Rattanajak; Uthai Arwon; Pascal Fantauzzi; Jirundon Yuvaniyama; William N Charman; David Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

9.  The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate.

Authors:  Ravi P Sahu; Sanjay K Srivastava
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

10.  Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models.

Authors:  Todd M Pitts; Mark Morrow; Sara A Kaufman; John J Tentler; S Gail Eckhardt
Journal:  Mol Cancer Ther       Date:  2009-01-27       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.